Document is current
Any future updates will be listed below
-
Authors
van Herk, Lukas https://orcid.org/0000-0002-7903-8997
Bruinsma, Bastiaan
de Weijer, Antoin
Geuze, Elbert
-
Funding
Funding for this research was provided by:
Ministerie van Defensie
- License Information
-
More Information
Article History
Received: 22 April 2026
Accepted: 23 July 2026
First Online: 6 August 2026
Declarations
Ethics approval: The study consisted of human participants and accordingly received ethical approval by the Medical Research Ethics Committee NedMec located in Utrecht, the Netherlands. Additionally, the study is in accordance with Good Clinical Practice (GCP) and the Declaration of Helsinki 2024. Informed consent of each participant was taken according to GCP standards.
Clinical trial number: The study was preregistered on 18th of July 2024 in the Clinical Trials Information System (CTIS), part of the World Health Organization (WHO) registry network, according to EU pharmaceutical law in the Clinical Trial Regulation – EU Clinical Trial number: 2023-508731-31-01.
Competing interests: The authors declare no competing interests.
